JEFFERSON CITY, Mo. (AP) — Agrochemical maker Bayer will pay up to $7.25 billion over two decades to resolve thousands of claims from U.S. cancer patients asserting the company should have warned people that its popular weed killer Roundup could cause lymphoma, according to a settlement approved Friday by a Missouri judge.
The nationwide settlement applies both to Roundup users who already are ill and those who become diagnosed with non-Hodgkin lymphoma in future years. Participants could get an average of between $10,000 and $165,000, depending on how they used the product, how old they were when diagnosed and the severity of their illness.
For Germany-based Bayer, which denies that Roundup causes cancer, the settlement provides some financial certainty against mounting litigation costs that have led it to contemplate pulling the product from U.S. agricultural markets. Bayer already has changed the formula for its Roundup version sold to residential users.
Litigants also faced uncertainty.…